As of 2026 there is no published peer-reviewed study testing BPC-157 and TB-500 together in any model cell, animal or human
Kennedy, Jr., secretary of the Department of Health and Human Services, proposed legalizing the compounding of 14 peptides and the FDA seems poised to grant his wish
Formulations with jojoba esters up to 90% reduced transepidermal water loss (TEWL) and increased barrier recovery by 81% (outperforming bisabolol at 47%)
The Wolverine BPC-157 & TB-500 Blend is engineered for researchers studying the complex mechanisms of angiogenesis and actin sequestration
Testing has found significant contamination rates in some peptide products, including incorrect amino acid sequences, endotoxin contamination, and mislabeling
Action of serotonin on the gastrointestinal tract. Proceedings of the Society for Experimental Biology and Medicine